Erie Indemnity Company (ERIE)
StalwartFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $213.05 |
| Market Cap | $11.8B |
| P/E Ratio | 19.51 |
| ROE | 25.85% |
| Dividend Yield | 2.58% |
| Sector | Financial Services |
Strengths
- Exceptional ROE of 26.19% demonstrates efficient capital deployment and business quality
- Ultra-conservative balance sheet with 0.03 D/E ratio provides financial flexibility and stability
- Unique managing general agent structure creates sticky revenue streams and switching costs
- Strong free cash flow generation of $499.9M enables reinvestment and shareholder returns
- Q4 2025 net margin of 19% shows operational excellence in insurance underwriting
Concerns
- Valuation is egregiously expensive at 599% premium to Graham Number—a severe margin of safety violation
- Piotroski F-Score of 2/9 signals deteriorating financial quality and earnings sustainability issues
- Extreme 52-week volatility ($247-$456.93) suggests speculative pricing divorced from fundamentals
- Missing revenue and profit growth rates raise questions about organic expansion capability
AI Analysis
I'm examining Erie Indemnity with cautious skepticism. On the surface, this managing general agent for Erie Insurance Exchange displays admirable financial discipline: a fortress balance sheet with D/E of 0.03, robust 26.19% ROE, and healthy free cash flow of $499.9M. The latest quarter shows 19% net margins—respectable for insurance operations. However, the valuation raises red flags that demand my attention. At $255.66 with a Graham Number of $36.56, this stock trades at a staggering 599% premium to intrinsic value. That's not a margin of safety; it's a margin of peril. The Piotroski F-Score of 2/9 suggests deteriorating financial quality, a warning sign I cannot ignore. The P/B of 5.50 is excessive even for quality operators. What troubles me most is the disconnect: strong ROE and cash generation exist alongside poor fundamental signals. The 52-week range of $247-$456.93 reveals extreme volatility, indicating speculative pricing rather than rational valuation. While ROCE of 14.81% exceeds cost of capital and the Altman Z-Score of 8.15 signals financial stability, I cannot justify paying $700 for a $100 asset. The company benefits from its unique positioning as the managing attorney-in-fact, providing sticky revenues and competitive advantages. But competitive moat alone doesn't excuse valuation excesses. I'd watch for revenue and profit growth acceleration, but currently, this represents poor risk-reward geometry.
Bull Case
Erie Indemnity's unique role as managing attorney-in-fact for a $50+ billion insurance exchange creates durable competitive advantages. Strong 26% ROE and 19% margins demonstrate business quality, while the fortress balance sheet enables counter-cyclical growth or acquisitions during downturns.
Bear Case
The 599% valuation premium to intrinsic value is indefensible regardless of quality. A deteriorating Piotroski F-Score coupled with missing growth metrics suggests the market has priced in perfection, leaving little room for disappointment or reversion.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer